Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 6, 2007

First New High Blood Pressure Drug in More Than a Decade Okayed

  • The first new type of high blood pressure medicine in more than a decade was approved, according to Novartis. Tekturna, developed by Novartis and Speedel, is a direct renin inhibitor. Renin is an enzyme that triggers a process, which can contribute to high blood pressure.

    "Renin angiotensin system activity contributes to many of the complications associated with high blood pressure," points out Marc A. Pfeffer, M.D., Ph.D., professor of medicine, Harvard Medical School and Cardiologist at Brigham & Women's Hospital. "By inhibiting this important system at its origin, renin production, a direct renin inhibitor, such as Tekturna, offers an exciting therapeutic option for treating hypertension."

    Tekturna was approved for the treatment of high blood pressure as a monotherapy or in combination with other high blood pressure medications.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »